National Institute on Drug Abuse (NIDA) Grant: Research on Prescription Drug Abuse (R21)

The National Institute on Drug Abuse (NIDA) is offering a grant to fund innovative research on prescription drug abuse. This grant aims to explore factors contributing to abuse, consequences, prevention methods, and treatments. Research across various methodologies, including basic science and clinical studies, is encouraged to understand the extent of the issue and identify affected populations. The focus includes all classes of prescription drugs with high abuse potential. Applicants can investigate individual-level, prescriber, and health system factors, as well as the relationship between prescribed medication and abuse risks. Deadline for applications is May 7, 2016.

Opportunity ID: 205494

Apply

General Information

Document Type::	Grants Notice
Funding Opportunity Number::	PA-13-016
Funding Opportunity Title::	Prescription Drug Abuse (R21)
Opportunity Category::	Discretionary
Opportunity Category Explanation::
Funding Instrument Type::
Category of Funding Activity::	Education
Category Explanation::
Expected Number of Awards::
Assistance Listings Number(s)::	93.279 — Drug Abuse and Addiction Research Programs
Cost Sharing or Matching Requirement::	No
Version::	Synopsis 3
Posted Date::	Nov 02, 2012
Last Updated Date::	Dec 16, 2015
Original Closing Date for Applications::	Jan 07, 2016
Current Closing Date for Applications::	May 07, 2016
Archive Date::	Jun 07, 2016
Estimated Total Program Funding::
Award Ceiling::	$200,000
Award Floor::	$

Eligibility

Eligible Applicants::

Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education

Additional Information on Eligibility::

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Additional Information

Agency Name::	National Institutes of Health
Description::	The National Institute on Drug Abuse (NIDA) encourages applicants to develop innovative research applications on prescription drug abuse, including research to examine the factors contributing to prescription drug abuse; to characterize the adverse medical, mental health and social consequences associated with prescription drug abuse; and to develop effective prevention and service delivery approaches and behavioral and pharmacological treatments. Applications to address these issues are encouraged across a broad range of methodological approaches including basic science, clinical, epidemiological, and health services research to define the extent of the problem of prescription drug abuse, to characterize this problem in terms of classes of drugs abused and combinations of drug types, etiology of abuse, and populations most affected (including analyses by age group, race/ethnicity, gender, and psychiatric symptomatology). Studies on individual- and patient-level factors, prescriber factors, and/or health system factors are encouraged, as are studies on all classes of prescription drugs with high abuse liability, including analgesics, stimulants, sedative/hypnotics and anxiolytics. Researchers are further encouraged to study the relationship between the prescription medication, the indication for which the medication was prescribed (e.g., pain, sleep disorder, anxiety disorder, obesity), and the environmental and individual factors contributing to abuse.
Link to Additional Information::
Grantor Contact Information::	If you have difficulty accessing the full announcement electronically, please contact:

Version History

Version	Modification Description	Updated Date
Synopsis 3	Modified the close date field in accordance with NOT-DA-16-010.	Dec 16, 2015
Synopsis 2	Modified the title.
Synopsis 1

Package Status

Below are CLOSED Opportunity Package(s) no longer available for this Funding Opportunity:

Package No: 1

Assistance Listings:	93.279
Competition ID:	ADOBE-FORMS-B2
Competition Title:	Adobe-Forms-B2
Opportunity Package ID:	PKG00150871
Opening Date:	Jan 16, 2013
Closing Date:	Sep 24, 2013
Agency Contact Information::	eRA Commons Help Desk
Who Can Apply::	Organization Applicants
mendatory_forms	SF424 (R & R) [V1.2] Project/Performance Site Location(s) [V1.4] Research And Related Other Project Information [V1.3] Research And Related Senior/Key Person Profile (Expanded) [V1.2] PHS 398 Cover Page Supplement [V1.4] PHS 398 Research Plan [V1.3] PHS 398 Checklist [V1.3]
optional_forms	R & R Subaward Budget Attachment(s) Form 5 YR 30 ATT [V1.2] PHS 398 Modular Budget [V1.2] Research & Related Budget [V1.1] PHS Cover Letter [V1.2]

Package No: 2